Haemato-oncology

These referrals are managed within the Specialist Integrated Haemato-oncology Diagnostic Service (SIHMDS).

For acute haematological malignancy or paediatric onset please also see Whole Genome Sequencing section.

We offer testing as outlined in the Test Directory for the disease entities as listed below.

• Acute Myeloid leukaemia (M80)
• Myelodysplasia (M82)
  
• Aplastic Anaemia (M83)
  
• Chronic Myeloid Leukaemia (M84)
  
• Myeloproliferative Neoplasm (M85)
  
• Chronic Neutrophilic Leukaemia (M87)
  
• Juvenile Myelomonocytic Leukaemia (M88)
  
• Acute Leukaemia - other (M89)
  
• Blastic Plasmacytoid Dendritic Cell Neoplasm (M90)
  
• Acute Lymphoblastic Leukaemia (M91)
  
• Lymphoma (M93)
  
• Chronic Lymphocytic Leukaemia (M94)
  
• B Cell Non-Hodgkin Lymphoma (M95)
  
• Burkitt Lymphoma (M96)
  
• Burkitt Like Lymphoma with 11q Abnormalities (M97)
  
• Large B Cell Like Lymphoma with IRF4 Rearrangement (M98)
  
• High Grade Lymphoma (M99)
  
• ALK Positive Large B Cell Lymphoma (M101 & M182)
  
• Mantle Cell Lymphoma (M102)
  
• Follicular Cell Lymphoma (M103)
  
• Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinaemia (M104)
  
• IgM Monoclonal Gammopathy of Uncertain Significance (M105)
  
• MALT Lymphoma (M107)
  
• Hairy Cell Leukaemia (M108)
  
• T Cell Non-Hodgkin Lymphoma (M111)
  
• ALK Negative Anaplastic Large Cell Lymphoma (including primary cutaneous subtypes) (M112)
  
• Studies following Allogeneic Haematopoietic Stem Cell Transplantation (M118)
  
• MDS / MPN (M224)
  
• Suspected Lymphoma (M225)